These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Susceptibility of multiresistant serotype 012 Pseudomonas aeruginosa to fosfomycin in combination with other antibiotics. Watine J; Bourrel C; Dubourdieu B; Gineston JL; Bories P; Durand M; Marre A; Formosa F; Brunel MP; Palliez J Pathol Biol (Paris); 1994 Apr; 42(4):293-5. PubMed ID: 7808781 [TBL] [Abstract][Full Text] [Related]
3. [Tricentric study of the sensitivity of Pseudomonas aeruginosa serotyping to beta-lactams and aminoglycosides]. Vachée A; Scheftel JM; Husson MO; Izard D; Ross P; Monteil H Pathol Biol (Paris); 1997 May; 45(5):357-62. PubMed ID: 9296084 [TBL] [Abstract][Full Text] [Related]
4. Role of ciprofloxacin in its synergistic effect with fosfomycin on drug-resistant strains of Pseudomonas aeruginosa. Yamada S; Hyo Y; Ohmori S; Ohuchi M Chemotherapy; 2007; 53(3):202-9. PubMed ID: 17356268 [TBL] [Abstract][Full Text] [Related]
5. [Evaluation of resistance of Pseudomonas aeruginosa isolates to select antibiotics]. Sekowska A; Janicka G; Wojda M; Wróblewska J; Manysiak S Pol Merkur Lekarski; 2005 Aug; 19(110):169-71. PubMed ID: 16245425 [TBL] [Abstract][Full Text] [Related]
6. Usefulness of a computerized expert system associated with systematic O-serotyping for the early detection of outbreaks of hospital acquired infections and for the presumptive antibiotic therapy of Pseudomonas aeruginosa infections. Watine J; Charet JC; Bruel A; Bouilloux JP; Palliez J Pathol Biol (Paris); 1996 Feb; 44(2):125-31. PubMed ID: 8761597 [TBL] [Abstract][Full Text] [Related]
7. [Pseudomonas aeruginosa: bactericidal activity on various beta-lactam resistance phenotypes of 8 antibiotics and 7 combinations]. Dubrous P; Cavallo JD; Hernandez E; Nordmann P; Fabre R Pathol Biol (Paris); 1997 May; 45(5):433-7. PubMed ID: 9296099 [TBL] [Abstract][Full Text] [Related]
8. In vitro investigations on the action fosfomycin alone and in combination with other antibiotics on Pseudomonas aeruginosa and Serratia marcescens. Ullmann U; Lindemann B Arzneimittelforschung; 1980; 30(8):1247-9. PubMed ID: 6776966 [TBL] [Abstract][Full Text] [Related]
9. [Preliminary study of the antagonistic effects between fosfomycin and beta-lactams on Pseudomonas aeruginosa observed on the antibiogram]. Buisson Y; Bercion R; Mauclère P; Hugard L; Schill H Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):671-4. PubMed ID: 3141886 [TBL] [Abstract][Full Text] [Related]
10. In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa. Pruekprasert P; Tunyapanit W Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1239-42. PubMed ID: 16438151 [TBL] [Abstract][Full Text] [Related]
11. [Microbiological study of 386 strains of Pseudomonas aeruginosa isolated in a 30-month span in the Isernia area with special reference to an antimicrobial assay carried out with the ABAC system on 214 of them]. Laurelli T; Ricci N; Ottaviano R; Manuppella AM; Petescia G Quad Sclavo Diagn; 1985 Dec; 21(4):469-82. PubMed ID: 3939383 [TBL] [Abstract][Full Text] [Related]
12. Synergistic effects of aminoglycosides and fosfomycin on Pseudomonas aeruginosa in vitro and biofilm infections in a rat model. Cai Y; Fan Y; Wang R; An MM; Liang BB J Antimicrob Chemother; 2009 Sep; 64(3):563-6. PubMed ID: 19561148 [TBL] [Abstract][Full Text] [Related]
13. [Surveillance of Pseudomonas aeruginosa sensitivity to antibiotics in France and distribution of beta-lactam resistance mechanisms: 1998 GERPB study]. Cavallo JD; Leblanc F; Fabre R Pathol Biol (Paris); 2000 Jun; 48(5):472-7. PubMed ID: 10949844 [TBL] [Abstract][Full Text] [Related]
14. [Correlation between sensitivity to fosfomycin and the presence of penicillinase PSE-1 in Pseudomonas aeruginosa]. Hance P; Fabre R; Leblanc F; Cavallo JD Pathol Biol (Paris); 2001 Feb; 49(1):12-5. PubMed ID: 11265218 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the in vitro activity of new beta-lactams and aminoglycosides against clinical isolates of Pseudomonas aeruginosa. Patzer J; Gieburowska R; Dzierzanowska D Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Oct; 253(1):110-20. PubMed ID: 6817544 [TBL] [Abstract][Full Text] [Related]
17. In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa. Tessier F; Quentin C Eur J Clin Microbiol Infect Dis; 1997 Feb; 16(2):159-62. PubMed ID: 9105845 [TBL] [Abstract][Full Text] [Related]
18. Serological and pyocin typing and antibiotic sensitivity of Pseudomonas aeruginosa strains. Del Piano M; La Palombara P; Picci A; Nicosia R Microbiologica; 1986 Apr; 9(2):253-8. PubMed ID: 3086671 [TBL] [Abstract][Full Text] [Related]
19. [Epidemiological studies of the susceptibility of Pseudomonas aeruginosa to antibiotics]. Bert F; Bruneau B; Lambert-Zechovsky N; Branger C Pathol Biol (Paris); 1994 May; 42(5):491-7. PubMed ID: 7824320 [TBL] [Abstract][Full Text] [Related]
20. The resistance patterns and serotypes of Pseudomonas aeruginosa strains isolated from children. Patzer J; Dzierzanowska D J Antimicrob Chemother; 1991 Dec; 28(6):869-75. PubMed ID: 1816183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]